You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsInformation about Individual Stocks

TenNor Therapeutics (Suzhou) Limited (06872)

Dano Pharmaceuticals was incorporated in 2013. It is a biotechnology company near commercialization that focuses on discovering, developing and commercializing differentiated innovative drug products to address unmet clinical needs in the fields of bacterial infections and bacterial metabolization-related diseases. With its self-developed multi-target coupled molecular technology, Danno is committed to providing patient